2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Metabolism and Cancer
Cancer metabolism is a rapidly growing area of research that explores how the altered metabolic processes in cancer cells support their uncontrolled growth and survival. Tumor cells often exhibit increased glucose uptake and preferential use of glycolysis, even in the presence of oxygen, a phenomenon known as the Warburg effect. This metabolic reprogramming not only promotes cell proliferation but also contributes to the resistance of cancer cells to chemotherapy and radiation. Researchers are identifying metabolic pathways and enzymes that could serve as therapeutic targets, aiming to disrupt these processes and selectively target cancer cells. A deeper understanding of cancer metabolism could lead to the development of novel treatments, including drugs that inhibit specific metabolic pathways, offering a potential new avenue for cancer therapy.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China